Cargando…
The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis
THE AIM: To investigate the role of Sirtuin 1 (SIRT1) level and SIRT1 (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS). METHODS: 79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031967/ https://www.ncbi.nlm.nih.gov/pubmed/36949521 http://dx.doi.org/10.1186/s13023-023-02665-x |
_version_ | 1784910701780795392 |
---|---|
author | Kubiliute, Aleksandra Gedvilaite, Greta Vilkeviciute, Alvita Kriauciuniene, Loresa Bruzaite, Akvile Zaliuniene, Dalia Liutkeviciene, Rasa |
author_facet | Kubiliute, Aleksandra Gedvilaite, Greta Vilkeviciute, Alvita Kriauciuniene, Loresa Bruzaite, Akvile Zaliuniene, Dalia Liutkeviciene, Rasa |
author_sort | Kubiliute, Aleksandra |
collection | PubMed |
description | THE AIM: To investigate the role of Sirtuin 1 (SIRT1) level and SIRT1 (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS). METHODS: 79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into 2 subgroups: patients with MS (n = 30) and patients without MS (n = 43). 6 ON patients did not have sufficient data for MS diagnosis and were excluded from the subgroup analysis. DNA was extracted from peripheral blood leukocytes and genotyped by real-time polymerase chain reaction. Results were analysed using the program "IBM SPSS Statistics 27.0". RESULTS: We discovered that SIRT1 rs3758391 was associated with a twofold increased odds of developing ON under the codominant (p = 0.007), dominant (p = 0.011), and over-dominant (p = 0.008) models. Also, it was associated with a threefold increased odds ofON with MS development under the dominant (p = 0.010), twofold increased odds under the over-dominant (p = 0.032) models and a 1.2-fold increased odds of ON with MS development (p = 0.015) under the additive model. We also discovered that the SIRT1 rs7895833 was significantly associated with a 2.5-fold increased odds of ON development under the codominant (p = 0.001), dominant (p = 0.006), and over-dominant (p < 0.001) models, and a fourfold increased odds of ON with MS development under the codominant (p < 0.001), dominant (p = 0.001), over-dominant (p < 0.001) models and with a twofold increased odds of ON with MS development (p = 0.013) under the additive genetic model. There was no association between SIRT1 levels and ON with/without MS development. CONCLUSIONS: SIRT1 rs3758391 and rs7895833 polymorphisms are associated with ON and ON with MS development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02665-x. |
format | Online Article Text |
id | pubmed-10031967 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100319672023-03-23 The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis Kubiliute, Aleksandra Gedvilaite, Greta Vilkeviciute, Alvita Kriauciuniene, Loresa Bruzaite, Akvile Zaliuniene, Dalia Liutkeviciene, Rasa Orphanet J Rare Dis Research THE AIM: To investigate the role of Sirtuin 1 (SIRT1) level and SIRT1 (rs3818292, rs3758391, rs7895833) gene polymorphisms in patients with optic neuritis (ON) and multiple sclerosis (MS). METHODS: 79 patients with ON and 225 healthy subjects were included in the study. ON patients were divided into 2 subgroups: patients with MS (n = 30) and patients without MS (n = 43). 6 ON patients did not have sufficient data for MS diagnosis and were excluded from the subgroup analysis. DNA was extracted from peripheral blood leukocytes and genotyped by real-time polymerase chain reaction. Results were analysed using the program "IBM SPSS Statistics 27.0". RESULTS: We discovered that SIRT1 rs3758391 was associated with a twofold increased odds of developing ON under the codominant (p = 0.007), dominant (p = 0.011), and over-dominant (p = 0.008) models. Also, it was associated with a threefold increased odds ofON with MS development under the dominant (p = 0.010), twofold increased odds under the over-dominant (p = 0.032) models and a 1.2-fold increased odds of ON with MS development (p = 0.015) under the additive model. We also discovered that the SIRT1 rs7895833 was significantly associated with a 2.5-fold increased odds of ON development under the codominant (p = 0.001), dominant (p = 0.006), and over-dominant (p < 0.001) models, and a fourfold increased odds of ON with MS development under the codominant (p < 0.001), dominant (p = 0.001), over-dominant (p < 0.001) models and with a twofold increased odds of ON with MS development (p = 0.013) under the additive genetic model. There was no association between SIRT1 levels and ON with/without MS development. CONCLUSIONS: SIRT1 rs3758391 and rs7895833 polymorphisms are associated with ON and ON with MS development. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02665-x. BioMed Central 2023-03-22 /pmc/articles/PMC10031967/ /pubmed/36949521 http://dx.doi.org/10.1186/s13023-023-02665-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Kubiliute, Aleksandra Gedvilaite, Greta Vilkeviciute, Alvita Kriauciuniene, Loresa Bruzaite, Akvile Zaliuniene, Dalia Liutkeviciene, Rasa The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis |
title | The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis |
title_full | The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis |
title_fullStr | The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis |
title_full_unstemmed | The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis |
title_short | The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis |
title_sort | role of sirt1 level and sirt1 gene polymorphisms in optic neuritis patients with multiple sclerosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031967/ https://www.ncbi.nlm.nih.gov/pubmed/36949521 http://dx.doi.org/10.1186/s13023-023-02665-x |
work_keys_str_mv | AT kubiliutealeksandra theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT gedvilaitegreta theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT vilkeviciutealvita theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT kriauciunieneloresa theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT bruzaiteakvile theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT zaliunienedalia theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT liutkevicienerasa theroleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT kubiliutealeksandra roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT gedvilaitegreta roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT vilkeviciutealvita roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT kriauciunieneloresa roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT bruzaiteakvile roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT zaliunienedalia roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis AT liutkevicienerasa roleofsirt1levelandsirt1genepolymorphismsinopticneuritispatientswithmultiplesclerosis |